Acid-secretory response and parietal cell sensitivity in patients with duodenal ulcer before and after treatment with sucralfate or ranitidine.

[1]  R. Hunt,et al.  Alteration of H2 receptor sensitivity in duodenal ulcer patients after maintenance treatment with an H2 receptor antagonist. , 1988, Gut.

[2]  A. Berstad,et al.  Augmented postprandial gastric acid secretion due to exposure to ranitidine in healthy subjects. , 1986, Scandinavian journal of gastroenterology.

[3]  J. Achord.  Gastric pepsin and acid secretion in patients with acute and healed duodenal ulcer , 1981 .

[4]  G. Bodemar,et al.  Short- and long-term treatment with cimetidine in peptic ulcer disease and the pharmacokinetics of cimetidine. , 1979, Scandinavian journal of gastroenterology. Supplement.

[5]  A. Berstad,et al.  Parietal and chief cell sensitivity to pentagastrin stimulation before and after cimetidine treatment for duodenal ulcer. , 1979, Scandinavian journal of gastroenterology.

[6]  A. Berstad,et al.  Parietal and chief cell sensitivity to histamine and pentagastrin stimulation before and after cimetidine treatment in healthy subjects. , 1979, Scandinavian journal of gastroenterology.

[7]  S. Bank,et al.  Effect of prolonged cimetidine therapy on gastric acid secretion in man. , 1978, Gut.

[8]  J. Isenberg,et al.  Increased sensitivity to stimulation of acid secretion by pentagastrin in duodenal ulcer. , 1975, The Journal of clinical investigation.

[9]  M. Roland.  Gastric secretory response to graded doses of pentagastrin alone or in combination with carbacholine in unoperated duodenal ulcer patients. , 1975, Scandinavian journal of gastroenterology.

[10]  L. Olbe,et al.  Gastric acid response to antrum distension in man. , 1975, Scandinavian journal of gastroenterology.

[11]  L. R. Celestin.  Antral activity and symptom periodicity in duodenal ulceration. , 1967, Gut.